Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · Real-Time Price · USD
43.67
+0.55 (1.28%)
Dec 20, 2024, 4:00 PM EST - Market closed

Korro Bio Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
45.0836.5421.3914.06
Research & Development
50.684837.6121.43
Operating Expenses
95.7684.535935.49
Operating Income
-95.76-84.53-59-35.49
Other Non Operating Income (Expenses)
7.993.390.9813.54
Pretax Income
-87.77-81.15-58.02-21.96
Income Tax Expense
0.040.030.010
Net Income
-87.81-81.17-58.03-21.96
Net Income to Common
-87.81-81.17-58.03-21.96
Shares Outstanding (Basic)
8204
Shares Outstanding (Diluted)
8204
Shares Change (YoY)
31.62%499.32%-94.26%-
EPS (Basic)
-11.11-53.08-227.42-4.94
EPS (Diluted)
-11.11-53.08-227.42-4.94
Free Cash Flow
-91.79-75.12-58.86-36.54
Free Cash Flow Per Share
-11.62-49.12-230.65-8.22
EBITDA
-92.47-80.9-56.49-33.9
D&A For EBITDA
3.33.632.511.6
EBIT
-95.76-84.53-59-35.49
Source: S&P Capital IQ. Standard template. Financial Sources.